Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9604973
Anti-cancer polyketide compounds
granted patentUS 9604907
Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotroph
granted patentUS 9598395
Premature-termination-codons readthrough compounds
granted patentUS 9596855
Small molecule inhibitors of biofilm formation and the novel use of previously identified
granted patentUS 9597336
Therapy for treatment of chronic degenerative brain diseases and nervous system injury
granted patentUS 9598404
Deoxycytidine kinase inhibitors
granted patentUS 9597372
Vault complexes for cytokine delivery
granted patentUS 9597427
Radioactive bone cement
granted patentUS 9592309
Positron emission tomography probe to monitor selected sugar metabolism in vivo
granted patentUS 9593162
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
granted patentUS 9592265
Modulation of oxidative stress, inflammation, and impaired insulin sensitivity with grape
granted patentUS 9592256
Compositions and methods for tissue repair with extracellular matrices
granted patentUS 9588124
Shape tunable plasmonic nanoparticles
granted patentUS 9585935
Intranasal oxytocin treatment to improve schizophrenia
granted patentUS 9585936
Method for therapeutic replenishment and enrichment of ocular surface lubrication
granted patentUS 9587020
Chimeric antigen receptor and methods of use thereof
granted patentUS 9587282
Adeno-associated virus virions with variant capsid and methods of use thereof
granted patentUS 9579346
Treatment of macrophage-related disorders
granted patentUS 9579400
Nanocarriers for drug delivery
granted patentUS 9580427
Kinase inhibitors
granted patentUS 9572862
Methods for promoting lipolysis and oxidation in liver and adipose tissue using catestatin
granted patentUS 9572873
Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral
granted patentUS 9573977
Method for preventing neoplastic transformation by inhibition of retinoblastoma protein in
granted patentUS 9567592
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a
granted